Neurology

Latest News

Lecanemab-irmb Approved for Alzheimer Disease
Lecanemab-irmb Approved for Alzheimer Disease

February 22nd 2024

On January 6, 2023, the FDA granted lecanemab-irmb (Leqembi) accelerated approval for treating mild cognitive impairment and mild dementia in patients with Alzheimer disease.

Biogen Ends Development, Sales of Aducanumab for Alzheimer Disease
Biogen Ends Development, Sales of Aducanumab for Alzheimer Disease

January 31st 2024

Latest CME Events & Activities

Advancing Alzheimer Disease Treatment: Updates and Insights for Managed Care

2.0 Credits / Neurology

View More

Treatment Advancements and Management Strategies in Bipolar Disorder to Mitigate Challenges to Patient Care

1.0 Credit / Neurology, Psychiatry

View More

A Managed Care Focus on Assessing the Armamentarium for Multiple Sclerosis to Better Individualize Treatment

1.5 Credits / Neurology

View More

The Value of Early Intervention With Long-Acting Injectable Antipsychotics to Improve Adherence and Treatment of Schizophrenia

1.5 Credits / Neurology, Psychiatry

View More

The Promising Role of Novel and Emerging Therapies for Amyotrophic Lateral Sclerosis: Clinical and Managed Care Insights

1.0 Credit / Neurology

View More

Understanding the Role of IVIg and SCIg for the Management of CIDP: Information the Pharmacist Needs to Know to Optimize Care, featuring a Patient Perspective

1.5 Credits / Immunology, Neurology

View More

Rare and Treatment-Resistant Epilepsy Syndromes: Identifying and Addressing the Unmet Needs of Patients and Recognizing Opportunities for Pharmacist Intervention

1.5 Credits / Neurology

View More

Strategies for the Management and Treatment of ALS: The Value of Early Diagnosis and Clinical Intervention

3.0 Credits / Neurology

View More

Leveraging Managed Care to Optimize Best Practices in the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

1.0 Credit / Neurology

View More

Improving Outcomes and Quality of Care in Spinal Muscular Atrophy: Updates in Treatment Advances

2.0 Credits / Neurology

View More

Navigating the Use of Targeted Therapies and Individualizing Care for Patients With Ulcerative Colitis

1.5 Credits / Gastroenterology

View More

New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist

1.0 Credit / Neurology

View More

Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden

1.5 Credits / Neurology

View More

Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care

1.5 Credits / Neurology

View More

Advances in Pharmacotherapy for Excessive Daytime Sleepiness Due to Narcolepsy

2.0 Credits / Neurology

View More

The Role of Long-Term Care and Consultant Pharmacists in the Management of Tardive Dyskinesia

1.0 Credit / Neurology

View More

© 2024 MJH Life Sciences

All rights reserved.